Etid klinik pou BPCO nan Arizona
16 etid pou BPCO ap chèche patisipan nan sit nan Arizona.
Vil nan Arizona
Tèks ofisyèl etid la (Anglè)
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- DM Clinical Research - Phoenix, Phoenix
Ap rekriteFaz 2
Laj 40 a 85 · Tout sèks · Mizajou Sep 30, 2026 · NCT07684820Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Chandler Clinical Research Trials- Site Number : 8400025, Chandler
- Pulmonary Associates - Phoenix - East Bell Road- Site Number : 8400114, Phoenix
- Epic Medical Research - Surprise- Site Number : 8400096, Surprise
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07190209An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Banner University Medical Center, Phoenix
Ap rekrite
Laj 40 a 80 · Tout sèks · Mizajou Sep 17, 2026 · NCT06035120Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Tucson Clinical Research Institute- Site Number : 8400006, Tucson
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07190222A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Phoenix
- Research Site, Phoenix
- Research Site, Phoenix
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Arizona- Tuscon, Tucson
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Phoenix
- Research Site, Phoenix
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06883305A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Phoenix
- Research Site, Scottsdale
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06878261A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Chandler Clinical Trials, Chandler
- Pulmonary Associates, PA, Phoenix
Ap rekriteFaz 2/3
Laj 35 a 80 · Tout sèks · Mizajou Aug 31, 2026 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Gilbert
- Research Site, Mesa
- Research Site, Mesa
- ak 2 plis
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Aug 26, 2026 · NCT06283966A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 102, Phoenix
- GC2501 Study Site 107, Scottsdale
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Aug 11, 2026 · NCT07555483STRIVE Post-Market Registry Study
- Dignity Health St. Joseph's Hospital and Medical Center, Phoenix
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT04302272SPIROMICS Study of Early COPD Progression (SOURCE)
- Mayo Clinic Arizona, Scottsdale
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 30 a 55 · Tout sèks · Mizajou Jun 3, 2026 · NCT05033990Pulmonary Rehabilitation for Rural Patients With COPD
- Mayo Clinic in Arizona, Scottsdale
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou May 7, 2026 · NCT06847061Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Banner Health, Gilbert
Ap rekrite
Laj 40 a 84 · Tout sèks · Mizajou Apr 24, 2026 · NCT06891755myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- Honor Health, Scottsdale
Ap rekrite
Laj 30 ak plis · Tout sèks · Mizajou Feb 6, 2025 · NCT05204888Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.